[1]
2026. Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting . Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Jan. 2026), e2026013. DOI:https://doi.org/10.4084/MJHID.2026.013.